| Snowy Range Health Center | |
|
100 S 6th St Laramie WY 82070-3239 | |
| (307) 460-9888 | |
| (307) 460-9892 |
| Full Name | Snowy Range Health Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 100 S 6th St, Laramie, Wyoming |
| Authorized Official Name and Position | Wendy B King (OWNER) |
| Authorized Official Contact | 3077212880 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Snowy Range Health Center Po Box 1126 Laramie WY 82073-1126 Ph: (307) 460-9888 | Snowy Range Health Center 100 S 6th St Laramie WY 82070-3239 Ph: (307) 460-9888 |
| NPI Number | 1831580240 |
|---|---|
| Provider Enumeration Date | 02/07/2015 |
| Last Update Date | 01/22/2021 |
| Medicare PECOS PAC ID | 8123337011 |
|---|---|
| Medicare Enrollment ID | O20151015000937 |
News Archive
The use of antiepileptic drugs is associated with a higher risk of death among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland.
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831580240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Secondary |
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
| Provider Name | Wendy Burleigh King |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235210451 PECOS PAC ID: 2163417965 Enrollment ID: I20101206000993 |
News Archive
The use of antiepileptic drugs is associated with a higher risk of death among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland.
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
› Verified 9 days ago
| Provider Name | Peggy Joyce Harris |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073753026 PECOS PAC ID: 7416237979 Enrollment ID: I20161129002676 |
News Archive
The use of antiepileptic drugs is associated with a higher risk of death among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland.
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
› Verified 9 days ago
News Archive
The use of antiepileptic drugs is associated with a higher risk of death among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland.
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.
Cell Therapeutics, Inc. today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone.
› Verified 9 days ago
Dini Chiropractic Center Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 253 N 3rd St, Laramie, WY 82072 Phone: 307-742-9378 Fax: 307-742-9379 | |
Ivinson Memorial Hospital Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3116 Willett Dr, Laramie, WY 82072 Phone: 307-742-6319 Fax: 307-742-6346 | |
Bestmed Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3810 E Grand Ave, Laramie, WY 82070 Phone: 307-721-1794 Fax: 307-721-1795 | |
Peak Wellness Center, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1263 N 15th St, Laramie, WY 82072 Phone: 307-745-8915 | |
Mountain View Physicians, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2710 Harney St Ste 100, Laramie, WY 82072 Phone: 307-742-9116 Fax: 307-745-8167 | |
High Performance Sports Medicine Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 406 S. 2nd Street, Laramie, WY 82070 Phone: 307-514-4041 | |
University Of Wyoming Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1000 E University Ave, Laramie, WY 82071 Phone: 307-766-2323 |